Paragon Associates & Paragon Associates II Joint Venture Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
APA Corp
APA
|
+$872K |
| 2 |
IRIDEX
IRIX
|
+$323K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$21.4M |
| 2 |
ATN International
ATNI
|
+$400K |
| 3 |
CVSA
Covista Inc
CVSA
|
+$222K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 73.87% |
| 2 | Materials | 18.83% |
| 3 | Healthcare | 4.85% |
| 4 | Real Estate | 2.46% |
| 5 | Communication Services | 0% |
Similar funds
Paragon Associates & Paragon Associates II Joint Venture's Q1 2022 Portfolio in Review
As of Q1 2022, Paragon Associates & Paragon Associates II Joint Venture held 10 positions worth $53.7M, down 14% from $62.5M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Paragon Associates & Paragon Associates II Joint Venture withdrew a net $20.8M in Q1 2022, closing 3 positions. Its most notable exit was State Street SPDR S&P 500 ETF Trust, an estimated $21.4M position sold in full.
By sector, the portfolio is most concentrated in Energy at 74% of assets, up from 44% a quarter earlier, followed by Materials and Healthcare.
Against the trend, Paragon Associates & Paragon Associates II Joint Venture added an estimated $872K to APA Corp.
- Paragon Associates & Paragon Associates II Joint Venture added most to APA Corp in Q1 2022, an estimated $872K increase.
- Paragon Associates & Paragon Associates II Joint Venture fully exited State Street SPDR S&P 500 ETF Trust in Q1 2022, selling an estimated $21.4M.
- Paragon Associates & Paragon Associates II Joint Venture's ten largest holdings make up 100% of its $53.7M portfolio in Q1 2022.
- Paragon Associates & Paragon Associates II Joint Venture opened 0 new positions and closed 3 in Q1 2022.
- Paragon Associates & Paragon Associates II Joint Venture's portfolio value fell 14% quarter-over-quarter to $53.7M.
Based on Paragon Associates & Paragon Associates II Joint Venture's 13F filing for Q1 2022, filed 16 May 2022.